Big Molecule Watch

SEPTEMBER 25, 2023

Last week, FDA released a draft guidance, “ Labeling for Biosimilar and Interchangeable Biosimilar Products ” (“2023 Draft Guidance”) that—when finalized—will revise and replace its July 2018 final guidance, “ Labeling for Biosimilar Products.” The fictitious example provided in the 2023 Draft Guidance is “replicamab-cznm.”

Labelling 62

Labelling Biosimilars Adverse Reactions Dosage 62

The Thyroid Pharmacist

DECEMBER 28, 2022

When it leaks into the bloodstream, the body does not recognize it, and labels the structure as a foreign invader and attacks it. Accessed February 25, 2018. link] Updated March 7, 2018. Accessed March 22, 2018. link] Accessed January 15, 2018. Understanding the stress response. Harvard Health Publishing.

Immunity 111

Immunity Immunization Doctor of Pharmacy Clinical Pharmacology 111

PharmaShots

MARCH 9, 2023

and medical doctor in clinical pharmacology Other Affiliations: She is a member of the Board of Directors of L’Oréal S.A Award & Nominations: Fiona has been awarded with the Prize for Women in Pharmacology from Astra Zeneca issued by the British Pharmacological Society in December 2018.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40